<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for PBTH</title>
    <link />
    <description>Headlines for PROLOR Biotech, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1407291-near-term-catalysts-and-high-insider-ownership-make-gtx-an-attractive-buy.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 09:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Near Term Catalysts And High Insider Ownership Makes GTx An Attractive Buy</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/gtxi/articles/185160/near-term-catalysts-and-high-insider-ownership-makes-gtx-an-attractive-buy/2013-05-07.aspx?source=itxwebtxt0000015</link>
      <author>Trefis</author>
      <pubDate>Tue, 07 May 2013 08:31:14 GMT</pubDate>
    </item>
    <item>
      <title>Opko's Next Acquisition?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1393341-opko-s-next-acquisition.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 02 May 2013 08:51:08 GMT</pubDate>
    </item>
    <item>
      <title>A Sweeter Deal On The Horizon For Prolor Biotech?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1391461-a-sweeter-deal-on-the-horizon-for-prolor-biotech.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 01 May 2013 17:46:09 GMT</pubDate>
    </item>
    <item>
      <title>Morning Market Movers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3489826/morning-market-movers.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 11 Apr 2013 10:10:50 GMT</pubDate>
    </item>
    <item>
      <title>PROLOR Biotech Wins Notice of Allowance for New US Patent Covering Long-Acting Coagulation Factors V</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/04/3477663/prolor-biotech-wins-notice-of-allowance-for-new-us-patent-covering-long-acting-co.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 08 Apr 2013 07:31:25 GMT</pubDate>
    </item>
    <item>
      <title>Adopt Prolor's Orphan Drug And Reward Your Portfolio</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1246371-adopt-prolor-s-orphan-drug-and-reward-your-portfolio.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 05 Mar 2013 02:27:16 GMT</pubDate>
    </item>
    <item>
      <title>PROLOR Shares Higher as EMA, EC Grant Orphan Drug Status for HGH-CTP</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3330467/prolor-shares-higher-as-ema-ec-grant-orphan-drug-status-for-hgh-ctp.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 13 Feb 2013 10:11:47 GMT</pubDate>
    </item>
    <item>
      <title>5 Biotech Stocks To Watch Under $5</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1098611-5-biotech-stocks-to-watch-under-5.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 07 Jan 2013 14:30:07 GMT</pubDate>
    </item>
    <item>
      <title>PROLOR Won New US Patent Covering CTP Platform for Long-Acting Therapeutic Proteins</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3219670/prolor-won-new-us-patent-covering-ctp-platform-for-long-acting-therapeutic-protei.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 07 Jan 2013 09:39:00 GMT</pubDate>
    </item>
    <item>
      <title>Is Prolor Biotech As Long Lasting As Its CTP Technology?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1089301-is-prolor-biotech-as-long-lasting-as-its-ctp-technology.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 01 Jan 2013 03:16:22 GMT</pubDate>
    </item>
    <item>
      <title>Takeaways From Teva's Analyst Day: 'Restoring Shareholder Value'</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1075331-takeaways-from-teva-s-analyst-day-restoring-shareholder-value.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 20 Dec 2012 11:25:57 GMT</pubDate>
    </item>
    <item>
      <title>Stock Watch Thursday, 20 December</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1074991-stock-watch-thursday-20-december.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 20 Dec 2012 09:20:59 GMT</pubDate>
    </item>
    <item>
      <title>Prolor Biotech: A Critical Year For Company With Results Expected For Lead Drug In Development</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1047781-prolor-biotech-a-critical-year-for-company-with-results-expected-for-lead-drug-in-development.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 05 Dec 2012 18:38:08 GMT</pubDate>
    </item>
    <item>
      <title>3 Pharmaceuticals With Promising Growth Catalysts To Consider Now</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1041291-3-pharmaceuticals-with-promising-growth-catalysts-to-consider-now.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 03 Dec 2012 11:06:49 GMT</pubDate>
    </item>
    <item>
      <title>Therapeutic Proteins Offer New Investment Opportunities</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1026111-therapeutic-proteins-offer-new-investment-opportunities.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sat, 24 Nov 2012 05:39:57 GMT</pubDate>
    </item>
    <item>
      <title>These 5 Insider Favorites Are Trading At Big Discounts To Target Price</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1002961-these-5-insider-favorites-are-trading-at-big-discounts-to-target-price.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 13 Nov 2012 10:27:43 GMT</pubDate>
    </item>
    <item>
      <title>Prolor Biotech To Benefit From 'Bio-Better' Drug As Novo Nordisk Pulls Out</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/939771-prolor-biotech-to-benefit-from-bio-better-drug-as-novo-nordisk-pulls-out.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 22 Oct 2012 17:29:38 GMT</pubDate>
    </item>
    <item>
      <title>Opko Health Continues To Sustain Strong Insider Support</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/896571-opko-health-continues-to-sustain-strong-insider-support.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 01 Oct 2012 06:54:25 GMT</pubDate>
    </item>
    <item>
      <title>3 Small Cap 'Buy' Rated Stocks With Institutional And Insider Buying</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/859571-3-small-cap-buy-rated-stocks-with-institutional-and-insider-buying.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 11 Sep 2012 09:12:27 GMT</pubDate>
    </item>
  </channel>
</rss>
